免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

ETEST普拉茚胺(PLZ)(0.016-256 µg/mL)

K号: K200512 · 2020-05-07

决定日期2020-05-07
产品代码JWY
咨询委员会抱歉,您提供的内容“MI”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

ETEST Plazomicin (PLZ) (0.016-256 µg/mL) is the device name listed in this FDA 510(k) record. The listed applicant is Biomérieux SA. It received FDA 510(k) clearance on 2020-05-07 under 510(k) number K200512. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the ETEST Plazomicin (PLZ) (0.016-256 µg/mL)?

ETEST Plazomicin (PLZ) (0.016-256 µg/mL) is a medical device that received FDA 510(k) clearance on 2020-05-07. The listed applicant is Biomérieux SA. The 510(k) number is K200512.

When did ETEST Plazomicin (PLZ) (0.016-256 µg/mL) receive FDA 510(k) clearance?

ETEST Plazomicin (PLZ) (0.016-256 µg/mL) received FDA 510(k) clearance on 2020-05-07, under 510(k) number K200512.

Who is the listed applicant for ETEST Plazomicin (PLZ) (0.016-256 µg/mL)?

The FDA 510(k) record lists Biomérieux SA as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ETEST Plazomicin (PLZ) (0.016-256 µg/mL)?

The FDA product code for ETEST Plazomicin (PLZ) (0.016-256 µg/mL) is JWY.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Biomérieux SA为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:JWY)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑